Issue 3/2019
Content (26 Articles)
Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas
Hongsai Chen, He Huang, Jingjing Zhao, Zhigang Wang, Mengling Chang, Lu Xue, Weidong Zhu, Yongchuan Chai, Gen Li, Zhaoyan Wang, Hao Wu
Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis
Lindsey Lowder, Jennifer Hauenstein, Ashley Woods, Hsiao-Rong Chen, Manali Rupji, Jeanne Kowalski, Jeffrey J. Olson, Debra Saxe, Matthew Schniederjan, Stewart Neill, Brent Weinberg, Soma Sengupta
Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres
Kavneet Kaur, Prerana Jha, Pankaj Pathak, Vaishali Suri, Mehar Chand Sharma, Ajay Garg, Ashish Suri, Chitra Sarkar
Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood–brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis
Samah A. Jassam, Zaynah Maherally, Keyoumars Ashkan, Geoffrey J. Pilkington, Helen L. Fillmore
Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells
Parvez Vora, Mathieu Seyfrid, Chitra Venugopal, Maleeha A. Qazi, Sabra Salim, Ruth Isserlin, Minomi Subapanditha, Erin O’Farrell, Sujeivan Mahendram, Mohini Singh, David Bakhshinyan, Chirayu Chokshi, Nicole McFarlane, Anna Dvorkin-Gheva, Kevin R. Brown, Naresh Murty, Jason Moffat, Gary D. Bader, Sheila K. Singh
Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell lines
Lei Zhang, John S. Yu
Satellite lesions of DNET: implications for seizure and tumor control after resection
Jeyul Yang, Seung-Ki Kim, Ki Joong Kim, Jong Hee Chae, Byung Chan Lim, Kyu-Chang Wang, Sung-Hye Park, Ji Hoon Phi
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial
Sara Pedretti, Laura Masini, Enrico Turco, Luca Triggiani, Marco Krengli, Bruno Meduri, Luigi Pirtoli, Paolo Borghetti, Ludovica Pegurri, Nada Riva, Roberto Gatta, Vincenzo Fusco, Silvia Scoccianti, Alessio Bruni, Umberto Ricardi, Riccardo Santoni, Stefano M. Magrini, Michela Buglione
Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system
Deborah Boyett, Connor J. Kinslow, Samuel S. Bruce, Adam M. Sonabend, Ali I. Rae, Guy M. McKhann, Michael B. Sisti, Jeffrey N. Bruce, Simon K. Cheng, Tony J. C. Wang
Effect of patient age on glioblastoma perioperative treatment costs: a value driven outcome database analysis
Brandon A. Sherrod, Nicholas T. Gamboa, Christopher Wilkerson, Herschel Wilde, Mohammed A. Azab, Michael Karsy, Randy L. Jensen, Sarah T. Menacho
Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature
Timothy K. Nguyen, James Perry, Arun N. E. Sundaram, Jay Detsky, Pejman J. Maralani, Eirena Calabrese, Sunit Das, Arjun Sahgal
Fronto-limbic white matter microstructure, behavior, and emotion regulation in survivors of pediatric brain tumor
Ryan Wier, Holly A. Aleksonis, Matthew M. Pearson, Christopher J. Cannistraci, Adam W. Anderson, John F. Kuttesch Jr., Bruce E. Compas, Kristen R. Hoskinson
Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study
Penghui Yan, Runzhi Huang, Peng Hu, Fengsen Liu, Xiaolong Zhu, Peizhu Hu, Huabin Yin, Jie Zhang, Tong Meng, Zongqiang Huang
First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial
Christopher J. Funes, Ryan A. Mace, Erik A. Macklin, Scott R. Plotkin, Justin T. Jordan, Ana-Maria Vranceanu
Contrast-enhancement in supratentorial low-grade gliomas: a classic prognostic factor in the molecular age
Florian Castet, Enrique Alanya, Noemi Vidal, Cristina Izquierdo, Carlos Mesia, François Ducray, Miguel Gil-Gil, Jordi Bruna
LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells
Guoxiong Li, Yingqian Cai, Chuanmei Wang, Min Huang, Jiansheng Chen
Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery
Eline Verhaak, Karin Gehring, Patrick E. J. Hanssens, Margriet M. Sitskoorn
Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences
Andrew Yousef, Martin J. Rutkowski, Can Ege Yalcin, Ozgur Can Eren, Ilay Caliskan, Tarik Tihan
Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer
Youngsan Ko, Ho-Shin Gwak, Eun Young Park, Jungnam Joo, Young Joo Lee, Sang Hyeon Lee, Ji-Woong Kwon, Sang-Hoon Shin, Heon Yoo
Comparative analysis of intracranial meningiomas in patients younger than 40 years
Tianhao Hu, Run Wang, Haiyun Wang, Yifu Song, Juanhan Yu, Di Zhang, Yang Jiang, Yuzhou Duan, Sheng Han
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)
Kurt A. Jaeckle, S. K. Anderson, Erin L. Twohy, Jesse G. Dixon, Caterina Giannini, Robert Jenkins, Merrill J. Egorin, Jann N. Sarkaria, Paul D. Brown, P. J. Flynn, John Schwerkoske, Jan C. Buckner, Evanthia Galanis
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)
Kurt A. Jaeckle, S. K. Anderson, Erin L. Twohy, Jesse G. Dixon, Caterina Giannini, Robert Jenkins, Merrill J. Egorin, Jann N. Sarkaria, Paul D. Brown, P. J. Flynn, John Schwerkoske, Jan C. Buckner, Evanthia Galanis
The case for radiosurgery for brainstem metastases
Evan Winograd, Charlotte I. Rivers, Robert Fenstermaker, Andrew Fabiano, Robert Plunkett, Dheerendra Prasad
Multisession radiosurgery for perioptic meningiomas: medium-to-long term results from a CyberKnife cooperative study
Marcello Marchetti, Alfredo Conti, Giancarlo Beltramo, Valentina Pinzi, Antonio Pontoriero, Irene Tramacere, Carolin Senger, Stefano Pergolizzi, Laura Fariselli
Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival model
Martin Connock, Peter Auguste, Claude Dussart, Jacques Guyotat, Xavier Armoiry
Applicability and limitations of a recently-proposed prognostic grading metric, initial brain metastasis velocity, for brain metastasis patients undergoing stereotactic radiosurgery
Masaaki Yamamoto, Hitoshi Aiyama, Takao Koiso, Shinya Watanabe, Takuya Kawabe, Yasunori Sato, Yoshinori Higuchi, Hidetoshi Kasuya, Bierta E. Barfod